These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1430 related items for PubMed ID: 26297559

  • 1. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R.
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [Abstract] [Full Text] [Related]

  • 2. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ.
    Acta Neurol Scand Suppl; 2012 Nov; (193):iv-22. PubMed ID: 23106488
    [Abstract] [Full Text] [Related]

  • 3. Blocking bad.
    Scherer SS.
    Brain; 2015 Nov; 138(Pt 11):3132-3. PubMed ID: 26503937
    [No Abstract] [Full Text] [Related]

  • 4. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G, Study Group for Hereditary Neuropathy in Japan.
    Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
    [Abstract] [Full Text] [Related]

  • 5. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu Hörste G, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW.
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [Abstract] [Full Text] [Related]

  • 6. Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X.
    Groh J, Weis J, Zieger H, Stanley ER, Heuer H, Martini R.
    Brain; 2012 Jan; 135(Pt 1):88-104. PubMed ID: 22094537
    [Abstract] [Full Text] [Related]

  • 7. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A, Berger P, Suter U.
    Neuromolecular Med; 2006 Jan; 8(1-2):217-42. PubMed ID: 16775378
    [Abstract] [Full Text] [Related]

  • 8. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
    Kobsar I, Hasenpusch-Theil K, Wessig C, Müller HW, Martini R.
    J Neurosci Res; 2005 Sep 15; 81(6):857-64. PubMed ID: 16041800
    [Abstract] [Full Text] [Related]

  • 9. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
    Rünker AE, Kobsar I, Fink T, Loers G, Tilling T, Putthoff P, Wessig C, Martini R, Schachner M.
    J Cell Biol; 2004 May 24; 165(4):565-73. PubMed ID: 15148307
    [Abstract] [Full Text] [Related]

  • 10. Role of immune cells in animal models for inherited peripheral neuropathies.
    Wang Ip C, Kroner A, Fischer S, Berghoff M, Kobsar I, Mäurer M, Martini R.
    Neuromolecular Med; 2006 May 24; 8(1-2):175-90. PubMed ID: 16775375
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies.
    Ip CW, Kroner A, Kohl B, Wessig C, Martini R.
    Neurobiol Dis; 2009 Feb 24; 33(2):207-12. PubMed ID: 19028581
    [Abstract] [Full Text] [Related]

  • 12. [Molecular genetics of inherited neuropathies].
    Takashima H.
    Rinsho Shinkeigaku; 2006 Jan 24; 46(1):1-18. PubMed ID: 16541790
    [Abstract] [Full Text] [Related]

  • 13. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.
    Sanmaneechai O, Feely S, Scherer SS, Herrmann DN, Burns J, Muntoni F, Li J, Siskind CE, Day JW, Laura M, Sumner CJ, Lloyd TE, Ramchandren S, Shy RR, Grider T, Bacon C, Finkel RS, Yum SW, Moroni I, Piscosquito G, Pareyson D, Reilly MM, Shy ME, Inherited Neuropathies Consortium - Rare Disease Clinical Research Consortium (INC-RDCRC).
    Brain; 2015 Nov 24; 138(Pt 11):3180-92. PubMed ID: 26310628
    [Abstract] [Full Text] [Related]

  • 14. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.
    Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M, Southwood C, Wu X, Gow A, Feltri ML, Wrabetz L, Shy ME.
    Brain; 2012 Jul 24; 135(Pt 7):2032-47. PubMed ID: 22689911
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of immune cells in animal models for inherited neuropathies: facts and visions.
    Mäurer M, Kobsar I, Berghoff M, Schmid CD, Carenini S, Martini R.
    J Anat; 2002 Apr 24; 200(4):405-14. PubMed ID: 12090406
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic features of inherited demyelinating neuropathies: a reappraisal.
    Lewis RA, Sumner AJ.
    Ann N Y Acad Sci; 1999 Sep 14; 883():321-35. PubMed ID: 10586257
    [Abstract] [Full Text] [Related]

  • 20. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
    Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW.
    Ann Neurol; 2007 Jan 14; 61(1):61-72. PubMed ID: 17262851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.